Pharmaceuticals and personal care products in the environment: what are the big questions?
- PMID: 22647657
- PMCID: PMC3440110
- DOI: 10.1289/ehp.1104477
Pharmaceuticals and personal care products in the environment: what are the big questions?
Abstract
Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment.
Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas.
Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance.
Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f ) antibiotic resistance, and g) risk management.
Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.
Conflict of interest statement
A.B.A.B., J.P.S., T.V., A.C., and P.C.D. have provided consultancy services to the pharmaceutical and personal care product (PPCP) industry. D.J.C., J.P.S., S.E.B., S.D.D., J.F.E., T.G., F.M., R.D.M., R.M.S., and J.O.S. are employed by the PPCP sector. A.B.A.B., B.W.B., K.C., J.P.S., T.V., A.C., P.C.D., F.G., J.P.G., M.V.K., D.G., J.L., J.M.L., J.L.P., M.E.M., M.R.S., P.K.S., E.T., G.R.T. V.L.T., and G.V., D.K. have received funding from industry and/or government for research on PPCP issues. M.A.R., D.J.C., S.E.B., P.C.D., F.M., R.D.M., J.R.S., and R.M.S. have shareholdings in the PPCP sector. S.H., E.I., K.O., G.T.A., K.F.B., J.P.B., P.C., L.H., A.M., R.M., and N.D.S. declare they have no actual or potential competing financial interests.
Figures


Similar articles
-
International scientists' priorities for research on pharmaceutical and personal care products in the environment.Integr Environ Assess Manag. 2014 Oct;10(4):576-87. doi: 10.1002/ieam.1551. Integr Environ Assess Manag. 2014. PMID: 24954797
-
Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.J Environ Manage. 2013 Nov 15;129:384-97. doi: 10.1016/j.jenvman.2013.06.035. Epub 2013 Aug 28. J Environ Manage. 2013. PMID: 23995140
-
Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.Environ Sci Pollut Res Int. 2006 Mar;13(2):110-9. doi: 10.1065/espr2005.08.276. Environ Sci Pollut Res Int. 2006. PMID: 16612900
-
Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China.Environ Int. 2013 Sep;59:208-24. doi: 10.1016/j.envint.2013.06.012. Epub 2013 Jul 6. Environ Int. 2013. PMID: 23838081 Review.
-
Emerging chemicals of concern: pharmaceuticals and personal care products (PPCPs) in Asia, with particular reference to Southern China.Mar Pollut Bull. 2005 Sep;50(9):913-20. doi: 10.1016/j.marpolbul.2005.06.034. Mar Pollut Bull. 2005. PMID: 16038943 Review.
Cited by
-
Identification and structural elucidation of ozonation transformation products of estrone.Chem Cent J. 2013 Apr 23;7(1):74. doi: 10.1186/1752-153X-7-74. Chem Cent J. 2013. PMID: 23618537 Free PMC article.
-
Human-use antibacterial residues in the natural environment of China: implication for ecopharmacovigilance.Environ Monit Assess. 2015 Jun;187(6):331. doi: 10.1007/s10661-015-4514-6. Epub 2015 May 7. Environ Monit Assess. 2015. PMID: 25947893
-
Hidden drivers of low-dose pharmaceutical pollutant mixtures revealed by the novel GSA-QHTS screening method.Sci Adv. 2016 Sep 7;2(9):e1601272. doi: 10.1126/sciadv.1601272. eCollection 2016 Sep. Sci Adv. 2016. PMID: 27617294 Free PMC article.
-
A prescription for drug-free rivers: uptake of pharmaceuticals by a widespread streamside willow.Environ Manage. 2019 Jan;63(1):136-147. doi: 10.1007/s00267-018-1120-8. Epub 2018 Nov 12. Environ Manage. 2019. PMID: 30421133
-
Simultaneous Determination of Pharmaceuticals by Solid-phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry: A Case Study from Sharjah Sewage Treatment Plant.Molecules. 2019 Feb 11;24(3):633. doi: 10.3390/molecules24030633. Molecules. 2019. PMID: 30754718 Free PMC article.
References
-
- Ankley GT, Brooks BW, Huggett DB, Sumpter JP. Repeating history: pharmaceuticals in the environment. Environ Sci Technol. 2007;41:8211–8217. - PubMed
-
- Barraclough D, Kearney T, Croxford A. Bound residues: environmental solution or future problem? Environ Pollut. 2005;133:85–90. - PubMed
-
- Berninger JP, Brooks BW. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol Lett. 2010;193:69–78. - PubMed
-
- Boxall ABA, Fogg LA, Kay P, Blackwell PA, Pemberton EJ, Croxford A. Prioritisation of veterinary medicines in the UK environment. Toxicol Lett. 2003b;142:207–218. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous